Reach (Ibr) — Baltimore, Maryland

Reach (Ibr) is a clinical research site located in Baltimore, Maryland, United States.

Crixeo Health Trust Score: 54/100 (POOR). This profile has not yet been claimed by the site owner.

Reach (Ibr) has participated in 1 clinical trials.

Therapeutic areas: Human Immunodeficiency Virus Infection, Hepatitis C.

Sponsors: G & W Laboratories Inc..

Sponsor Feasibility Report

Trust Score: 54/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Reach (Ibr)?

Reach (Ibr) has a Crixeo Trust Score of 54/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Reach (Ibr) conducted?

Reach (Ibr) has 1 clinical trials on record. Their work covers Human Immunodeficiency Virus Infection, Hepatitis C.

Is Reach (Ibr) accredited by Crixeo Health?

Reach (Ibr) has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Reach (Ibr)?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.